Ligand Pharmaceuticals | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
Amgen USD 1.69B 191M 2025-03
Arrowhead Research USD 30.2M 1.91M 2024-12
Baxter International USD 703M 88M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
Glaxosmithkline GBP 2.7B 632M 2024-12
Insmed USD 142.51M 23.58M 2024-12
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Ligand Pharmaceuticals USD 25.6M 1.13M 2024-12
MacroGenics USD 27.81M 13.71M 2024-12
Merck USD 2.53B 319M 2025-03
Pacira USD 79.61M 5.28M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Veracyte USD 50.72M 3.47M 2024-12



Ligand Pharmaceuticals Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - May 2025.